Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Cardio Systems, Inc. — Predicate Candidate Screening

9 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

133 daysmedian FDA review time
234 days90th percentile
9clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K131092STEALTH 360 ORBITAL PAD SYSTEMCardio Systems, Inc.2013-06-24670
K081944MODIFICATION TO DIAMONDBACK 360 DEGREE ORBITAL ATHERECTOMY SCardio Systems, Inc.2008-08-14370
K972022ZAK-2000Cardio Systems, Inc.1998-01-222340
K934689LOW AIR LOSS MATTRESS, MODIFICATIONCardio Systems, Inc.1994-02-021630
K921500CENTRI-SAFE(TM) VALVECardio Systems, Inc.1992-09-151680
K882177ADD-ON TO CRITICAL PATIENT CARE BEDCardio Systems, Inc.1988-12-011910
K852736BAYLOR RAPID AUTOTRANSFUSION SYSTEMCardio Systems, Inc.1985-09-181330
K792152CARDIOPLEGIA SOLUTION ADMIN. SETCardio Systems, Inc.1979-11-13220
K792151OXYGENATOR GAS LINE FILTERCardio Systems, Inc.1979-11-13220

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda